Skip to content
Xalatan, Roclanda(latanoprost)
Iyuzeh, Rocklatan, Roclanda, Xalatan, Xelpros (latanoprost) is a small molecule pharmaceutical. Latanoprost was first approved as Xalatan on 1996-06-05. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma. The pharmaceutical is active against prostaglandin F2-alpha receptor.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
Trade Name
FDA
EMA
Iyuzeh, Xalatan, Xelpros (generic drugs available since 2011-03-22)
Combinations
Rocklatan
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Latanoprost
Tradename
Company
Number
Date
Products
XELPROSsparcN-206185 RX2018-09-12
1 products, RLD, RS
IYUZEHThea PharmaN-216472 RX2022-12-13
1 products, RLD, RS
XALATANUpjohnN-020597 RX1996-06-05
1 products, RLD, RS
Latanoprost
+
Netarsudil dimesylate
Tradename
Company
Number
Date
Products
ROCKLATANAlcon ResearchN-208259 RX2019-03-12
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
latanoprostANDA2023-04-11
rocklatanNew Drug Application2021-12-03
xalatanNew Drug Application2019-05-17
xelprosNew Drug Application2021-01-06
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
open-angle glaucomaEFO_0004190D005902H40.1
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Latanoprost / Netarsudil Dimesylate, Rocklatan, Alcon Labs Inc
94150432034-03-14DP
99313362034-03-14DS, DPU-1524
99934702034-03-14DS, DPU-1524
105889012034-03-14DS, DPU-1524
111855382034-03-14DP
111978532034-03-14DP
83948262030-11-10DS, DPU-1524
101740172030-01-27DS, DPU-1524
106548442030-01-27DS, DPU-1524
110280812030-01-27U-1524
116187482030-01-27U-1524
84503442026-07-11DS, DPU-1524
90965692026-07-11DS, DPU-1524
105329932026-07-11U-1524
108828402026-07-11U-1524
110214562026-07-11U-1524
Latanoprost, Xelpros, Sun Pharm
96298522029-09-12DP
95392622028-10-15U-2400
ATC Codes
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01E: Antiglaucoma preparations and miotics
— S01EE: Prostaglandin analogues, antiglaucoma drugs and miotics
— S01EE01: Latanoprost
— S01EE51: Latanoprost and netarsudil
HCPCS
No data
Clinical
Clinical Trials
202 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ocular hypertensionD009798EFO_1001069H40.01343333010122
Open-angle glaucomaD005902EFO_0004190H40.183632257103
GlaucomaD005901EFO_0000516H405141032969
Intraocular pressureD007429—1—124
Angle-closure glaucomaD015812——1113
Alopecia areataD000506EFO_0004192L63———112
Diabetic retinopathyD003930EFO_0003770———112
Macular edemaD008269———1—1
Anterior uveitisD014606EFO_1000811———1—1
Dry eye syndromesD015352H04.12———1—1
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
VitiligoD014820EFO_0004208L80—22——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Meniere diseaseD008575EFO_0006862H81.0—1———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ocular physiological phenomenaD009799————22
Low tension glaucomaD057066EFO_1001022H40.12————11
Exfoliation syndromeD017889EFO_0004235————11
Regional blood flowD012039————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLATANOPROST
INNlatanoprost
Description
Latanoprost is a prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension. It has a role as an antiglaucoma drug, an antihypertensive agent, an EC 4.2.1.1 (carbonic anhydrase) inhibitor and a prodrug. It is a prostaglandins Falpha, a triol and an isopropyl ester. It is functionally related to a latanoprost free acid.
Classification
Small molecule
Drug classprostaglandins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1
Identifiers
PDB—
CAS-ID130209-82-4
RxCUI43611
ChEMBL IDCHEMBL1051
ChEBI ID6384
PubChem CID5311221
DrugBankDB00654
UNII ID6Z5B6HVF6O (ChemIDplus, GSRS)
Target
Agency Approved
PTGFR
PTGFR
Organism
Homo sapiens
Gene name
PTGFR
Gene synonyms
NCBI Gene ID
5737
Protein name
prostaglandin F2-alpha receptor
Protein synonyms
FP prostanoid receptor, PGF receptor, PGF2 alpha receptor, prostaglandin receptor (2-alpha), Prostanoid FP receptor
Uniprot ID
Q9P1X4
Mouse ortholog
Ptgfr (19220)
prostaglandin F2-alpha receptor (P43117)
Alternate
No data
Variants
Clinical Variant
No data
Financial
Xalatan - Pfizer
$
€
£
₣
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,810 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2,973 adverse events reported
View more details